BEGIN:VCALENDAR VERSION:2.0 PRODID:www.eu-parc.eu BEGIN:VEVENT UID:69e28acf4f67f DTSTART;VALUE=DATE:20250914 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20250915 SUMMARY:European Congress of Toxicology 2025 CLASS:PUBLIC DESCRIPTION:The EUROTOX 2025 – European Congress of Toxicology ↗ will t ake place from 14 to 17 September 2025 in Athens\, Greece. Recognized as E urope’s most prominent toxicology conference\, EUROTOX gathers leading s cientists\, regulators\, industry experts\, and academics to explore the m ost pressing issues and innovations in toxicology. The scientific programm e will emphasize emerging technologies\, advanced methodologies\, and inte rdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform fo r knowledge exchange and aims to foster critical discussions that will sha pe the future of toxicological science: \;Keynote lectures by renowned international expertsSessions on AI and computational toxicology\, exposu re science\, omics technologies\, and regulatory innovationsDedicated spac e for young researchers to present their work through oral and poster pres entationsNetworking events promoting collaboration across sectors and disc iplines \;The programme is designed to reflect the complexity of moder n toxicology\, addressing scientific\, ethical\, and regulatory challenges through multidisciplinary dialogue. \;PARC will have a significant pr esence at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The collective participation of PARC teams underlines the initiative’s critical role in advancing tox icology and public health research at the European level. \;Metabolic disruption of lipid metabolism in human liver cells presented by Neele Wew er (German Federal Institute for Risk Assessment ↗) Towards prospective identification of respiratory sensitizers: setting up a co-culture of bron chial epithelial and dendritic-like cells presented by Véronique de Bruij n (National Institute for Public Health and the Environment ↗\, Netherl ands)Involvement of glucocorticoid receptor in immunomodulation of THP-1 d erived macrophages by bisphenol A substitutes presented by Nina Franko (Fa culty of Pharmacy ↗\, Slovenia)Implementation of NAMs in Pesticide Dossi ers: Insights from PARC Project-PESTNAM presented by Emma Di Consiglio (It alian National Institute of Health ↗)Exploring Linkages between Thyroid Hormone System Disruption (THSD) and Metabolic Adverse Outcomes presented by Elisavet RenieriA Next Generation PBK model for PFOA in humans presente d by Chrysanthi Pachoulide (Wageningen University &\; Research ↗\, Ne therlands)The Genotoxic Potential of Emerging Bisphenol A Alternatives in an Advanced in vitro Zebrafish Hepatic Model presented by Alja Štern (Nat ional Institute of Biology ↗\, Slovenia)Adverse (geno)toxic effects of B PA\, its two analogues BPAP and BPC and their binary mixtures in in vitro 3D cell model presented by Martina  \;Štampar (National Institute of Biology ↗\, Slovenia)Cell dialogue in disarray: unraveling non-genotoxic carcinogens through disrupted connexin-based communication presented by P avel Babica (RECETOX ↗\, Czechia)Mechanistic Insights of BPA Alternative s on PPARγ Binding and Consequences on Adipocyte Differentiation presente d by Daniela Flores Gomez (Utrecht University ↗\, Netherlands)Cadmium in the Portuguese Diet: A Food Sustainability Perspective on Human Exposure from Plant- and Animal-Based Foods \; presented by Sónia Namorado (Po rtuguese National Institute of Health Dr. Ricardo Jorge\, Portugal) ↗Pr enatal mercury exposure and the associated risk: a call for preventive act ion based on Human Biomonitoring Data from Portuguese Pregnant Women prese nted by Sónia Namorado (Portuguese National Institute of Health Dr. Ricar do Jorge\, Portugal) \; ↗Establishment of Readiness Criteria for AI- based tools for risk assessment: READYAI presented by Joyce de Paula Souza (University of Basel ↗\, Switzerland)Assessment of the Metabolic Fate o f Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG ce lls presented by Louise Gütter (National Research Institute for Agricultu re\, Food and Environment ↗\, France)Biotransformation of the colour dev eloper Pergafast 201 in human in vitro models presented by Daniel Zalko (N ational Research Institute for Agriculture\, Food and Environment ↗\, Fr ance)How advancements in OECD genotoxicity TGs improve chemical safety ass essments and challenge retrospective data analysis for NAM based IATA deve lopment presented by Vasiliki Hatzi (Benaki Phytopathological Institute ↗\, Greece)Creation of a FAIR data policy for the Partnership for the As sessment of Risk from Chemicals (PARC). Exploring LLMs and data sciences f or identification of future topics and stakeholder interests presented by Rob Stierum (Netherlands Organization for Applied Scientific Research ↗) Use of New Approach Methodologies (NAMs) in unravelling interspecies Toxic okinetics of Enniatin B1 presented by Mariam Mahdjoub (French Agency for F ood\, Environmental and Occupational Health &\; Safety ↗)The PARC Rea l-life Mixtures Project: Mixture Risk Assessment Results of the Case Studi es on Pesticides\, PFAS and Heavy Metals presented by Hannah McKeon (Natio nal Institute for Public Health and the Environment ↗\, Netherlands)Asse ssment of the Metabolic Fate of Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG cells presented by Daniel Zalko (National Rese arch Institute for Agriculture\, Food and Environment ↗\, France)Neuroen docrine changes and oxidative stress following PFAS exposure using the Zeb rafish (Danio rerio) model \; presented by Sarah Elise Smebakk Nilsen (Norwegian University of Life Sciences ↗)Comparison of aggregate exposur e to PFAS from diet and environment sources with Spanish human biomonitori ng data \; presented by Noelia Domínguez-Morueco (Carlos III Health I nstitute ↗\, Spain)Human Choroid Plexus Organoid Model to Test Inhibitio n of Thyroid Hormone Transport across the Blood-Cerebrospinal fluid-Barrie r presented by Kim Heikamp (Vrije Universiteit Amsterdam ↗\, Netherlands )Mycotoxins from the Alternaria fungi sp. may modulate the activation of t he toll like receptor – NFkB-signalling pathway \; presented by Solv eig Krapf (National Institute of Occupational Health ↗\, Norway)Advancin g immunotoxicology with animal-free models: a novel approach for TD and TI antibody response assays presented by Martina Martina Iulini (Università degli Studi di Milano ↗\, Italy)WP3: PARC ambition for synergies and co mmunication to gain impact presented by Aglaia Koutsodimou (Independent Au thority of Public Revenue ↗\, Greece)Comparison of aggregate exposure to PFAS from diet and environment sources with Spanish human biomonitoring d ata \; presented by Domínguez-Morueco Noelia  \;(Carlos III Healt h Institute ↗\, Spain)Ensuring protocol robustness and integrity in the development of Adverse Outcome Pathway (AOP) for regulatory application pr esented by Barbara Viviani  \;(Università degli Studi di Milano ↗\, Italy) \; \; \;EUROTOX 2025 is a cornerstone event for profes sionals engaged in toxicology and chemical risk assessment. We warmly invi te all stakeholders\, scientists\, and policymakers to join this prestigio us congress in Athens. Engage in leading-edge discussions\, discover new c ollaborations\, and contribute to shaping the future of toxicology. X-ALT-DESC;FMTTYPE=text/html:

The EUROTOX 2025 – European Congress of Toxicology ↗ wil l take place from 14 to 17 September 2025 in Athens\, Greece. Recognized a s Europe’s most prominent toxicology conference\, EUROTOX gathers leadin g scientists\, regulators\, industry experts\, and academics to explore th e most pressing issues and innovations in toxicology. The scientific progr amme will emphasize emerging technologies\, advanced methodologies\, and i nterdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform for knowledge exchange and aims to foster critical discussions that will shape the future of toxicological science: \;

The p rogramme is designed to reflect the complexity of modern toxicology\, addr essing scientific\, ethical\, and regulatory challenges through multidisci plinary dialogue. \;

PARC will have a significant presen ce at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The col lective participation of PARC teams underlines the initiative’s critical role in advancing toxicology and public health research at the European l evel. \;

 \;

 \;

 \;

EUROTOX 2025 is a cornerstone event for professionals engaged in toxicology and chemical risk assessment. We warmly invite all stakeholders\, scientists\, and policymakers to join this prestigious cong ress in Athens. Engage in leading-edge discussions\, discover new collabor ations\, and contribute to shaping the future of toxicology.

X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260417T193231Z END:VEVENT BEGIN:VEVENT UID:69e28acf4f749 DTSTART;VALUE=DATE:20250915 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20250916 SUMMARY:European Congress of Toxicology 2025 CLASS:PUBLIC DESCRIPTION:The EUROTOX 2025 – European Congress of Toxicology ↗ will t ake place from 14 to 17 September 2025 in Athens\, Greece. Recognized as E urope’s most prominent toxicology conference\, EUROTOX gathers leading s cientists\, regulators\, industry experts\, and academics to explore the m ost pressing issues and innovations in toxicology. The scientific programm e will emphasize emerging technologies\, advanced methodologies\, and inte rdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform fo r knowledge exchange and aims to foster critical discussions that will sha pe the future of toxicological science: \;Keynote lectures by renowned international expertsSessions on AI and computational toxicology\, exposu re science\, omics technologies\, and regulatory innovationsDedicated spac e for young researchers to present their work through oral and poster pres entationsNetworking events promoting collaboration across sectors and disc iplines \;The programme is designed to reflect the complexity of moder n toxicology\, addressing scientific\, ethical\, and regulatory challenges through multidisciplinary dialogue. \;PARC will have a significant pr esence at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The collective participation of PARC teams underlines the initiative’s critical role in advancing tox icology and public health research at the European level. \;Metabolic disruption of lipid metabolism in human liver cells presented by Neele Wew er (German Federal Institute for Risk Assessment ↗) Towards prospective identification of respiratory sensitizers: setting up a co-culture of bron chial epithelial and dendritic-like cells presented by Véronique de Bruij n (National Institute for Public Health and the Environment ↗\, Netherl ands)Involvement of glucocorticoid receptor in immunomodulation of THP-1 d erived macrophages by bisphenol A substitutes presented by Nina Franko (Fa culty of Pharmacy ↗\, Slovenia)Implementation of NAMs in Pesticide Dossi ers: Insights from PARC Project-PESTNAM presented by Emma Di Consiglio (It alian National Institute of Health ↗)Exploring Linkages between Thyroid Hormone System Disruption (THSD) and Metabolic Adverse Outcomes presented by Elisavet RenieriA Next Generation PBK model for PFOA in humans presente d by Chrysanthi Pachoulide (Wageningen University &\; Research ↗\, Ne therlands)The Genotoxic Potential of Emerging Bisphenol A Alternatives in an Advanced in vitro Zebrafish Hepatic Model presented by Alja Štern (Nat ional Institute of Biology ↗\, Slovenia)Adverse (geno)toxic effects of B PA\, its two analogues BPAP and BPC and their binary mixtures in in vitro 3D cell model presented by Martina  \;Štampar (National Institute of Biology ↗\, Slovenia)Cell dialogue in disarray: unraveling non-genotoxic carcinogens through disrupted connexin-based communication presented by P avel Babica (RECETOX ↗\, Czechia)Mechanistic Insights of BPA Alternative s on PPARγ Binding and Consequences on Adipocyte Differentiation presente d by Daniela Flores Gomez (Utrecht University ↗\, Netherlands)Cadmium in the Portuguese Diet: A Food Sustainability Perspective on Human Exposure from Plant- and Animal-Based Foods \; presented by Sónia Namorado (Po rtuguese National Institute of Health Dr. Ricardo Jorge\, Portugal) ↗Pr enatal mercury exposure and the associated risk: a call for preventive act ion based on Human Biomonitoring Data from Portuguese Pregnant Women prese nted by Sónia Namorado (Portuguese National Institute of Health Dr. Ricar do Jorge\, Portugal) \; ↗Establishment of Readiness Criteria for AI- based tools for risk assessment: READYAI presented by Joyce de Paula Souza (University of Basel ↗\, Switzerland)Assessment of the Metabolic Fate o f Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG ce lls presented by Louise Gütter (National Research Institute for Agricultu re\, Food and Environment ↗\, France)Biotransformation of the colour dev eloper Pergafast 201 in human in vitro models presented by Daniel Zalko (N ational Research Institute for Agriculture\, Food and Environment ↗\, Fr ance)How advancements in OECD genotoxicity TGs improve chemical safety ass essments and challenge retrospective data analysis for NAM based IATA deve lopment presented by Vasiliki Hatzi (Benaki Phytopathological Institute ↗\, Greece)Creation of a FAIR data policy for the Partnership for the As sessment of Risk from Chemicals (PARC). Exploring LLMs and data sciences f or identification of future topics and stakeholder interests presented by Rob Stierum (Netherlands Organization for Applied Scientific Research ↗) Use of New Approach Methodologies (NAMs) in unravelling interspecies Toxic okinetics of Enniatin B1 presented by Mariam Mahdjoub (French Agency for F ood\, Environmental and Occupational Health &\; Safety ↗)The PARC Rea l-life Mixtures Project: Mixture Risk Assessment Results of the Case Studi es on Pesticides\, PFAS and Heavy Metals presented by Hannah McKeon (Natio nal Institute for Public Health and the Environment ↗\, Netherlands)Asse ssment of the Metabolic Fate of Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG cells presented by Daniel Zalko (National Rese arch Institute for Agriculture\, Food and Environment ↗\, France)Neuroen docrine changes and oxidative stress following PFAS exposure using the Zeb rafish (Danio rerio) model \; presented by Sarah Elise Smebakk Nilsen (Norwegian University of Life Sciences ↗)Comparison of aggregate exposur e to PFAS from diet and environment sources with Spanish human biomonitori ng data \; presented by Noelia Domínguez-Morueco (Carlos III Health I nstitute ↗\, Spain)Human Choroid Plexus Organoid Model to Test Inhibitio n of Thyroid Hormone Transport across the Blood-Cerebrospinal fluid-Barrie r presented by Kim Heikamp (Vrije Universiteit Amsterdam ↗\, Netherlands )Mycotoxins from the Alternaria fungi sp. may modulate the activation of t he toll like receptor – NFkB-signalling pathway \; presented by Solv eig Krapf (National Institute of Occupational Health ↗\, Norway)Advancin g immunotoxicology with animal-free models: a novel approach for TD and TI antibody response assays presented by Martina Martina Iulini (Università degli Studi di Milano ↗\, Italy)WP3: PARC ambition for synergies and co mmunication to gain impact presented by Aglaia Koutsodimou (Independent Au thority of Public Revenue ↗\, Greece)Comparison of aggregate exposure to PFAS from diet and environment sources with Spanish human biomonitoring d ata \; presented by Domínguez-Morueco Noelia  \;(Carlos III Healt h Institute ↗\, Spain)Ensuring protocol robustness and integrity in the development of Adverse Outcome Pathway (AOP) for regulatory application pr esented by Barbara Viviani  \;(Università degli Studi di Milano ↗\, Italy) \; \; \;EUROTOX 2025 is a cornerstone event for profes sionals engaged in toxicology and chemical risk assessment. We warmly invi te all stakeholders\, scientists\, and policymakers to join this prestigio us congress in Athens. Engage in leading-edge discussions\, discover new c ollaborations\, and contribute to shaping the future of toxicology. X-ALT-DESC;FMTTYPE=text/html:

The EUROTOX 2025 – European Congress of Toxicology ↗ wil l take place from 14 to 17 September 2025 in Athens\, Greece. Recognized a s Europe’s most prominent toxicology conference\, EUROTOX gathers leadin g scientists\, regulators\, industry experts\, and academics to explore th e most pressing issues and innovations in toxicology. The scientific progr amme will emphasize emerging technologies\, advanced methodologies\, and i nterdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform for knowledge exchange and aims to foster critical discussions that will shape the future of toxicological science: \;

  • Keynote lectu res by renowned international experts
  • Sessions on AI and computati onal toxicology\, exposure science\, omics technologies\, and regulatory i nnovations
  • Dedicated space for young researchers to present their work through oral and poster presentations
  • Networking events promo ting collaboration across sectors and disciplines \;

The p rogramme is designed to reflect the complexity of modern toxicology\, addr essing scientific\, ethical\, and regulatory challenges through multidisci plinary dialogue. \;

PARC will have a significant presen ce at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The col lective participation of PARC teams underlines the initiative’s critical role in advancing toxicology and public health research at the European l evel. \;

 \;

 \;

 \;

EUROTOX 2025 is a cornerstone event for professionals engaged in toxicology and chemical risk assessment. We warmly invite all stakeholders\, scientists\, and policymakers to join this prestigious cong ress in Athens. Engage in leading-edge discussions\, discover new collabor ations\, and contribute to shaping the future of toxicology.

X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260417T193231Z END:VEVENT BEGIN:VEVENT UID:69e28acf4f764 DTSTART;VALUE=DATE:20250916 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20250917 SUMMARY:European Congress of Toxicology 2025 CLASS:PUBLIC DESCRIPTION:The EUROTOX 2025 – European Congress of Toxicology ↗ will t ake place from 14 to 17 September 2025 in Athens\, Greece. Recognized as E urope’s most prominent toxicology conference\, EUROTOX gathers leading s cientists\, regulators\, industry experts\, and academics to explore the m ost pressing issues and innovations in toxicology. The scientific programm e will emphasize emerging technologies\, advanced methodologies\, and inte rdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform fo r knowledge exchange and aims to foster critical discussions that will sha pe the future of toxicological science: \;Keynote lectures by renowned international expertsSessions on AI and computational toxicology\, exposu re science\, omics technologies\, and regulatory innovationsDedicated spac e for young researchers to present their work through oral and poster pres entationsNetworking events promoting collaboration across sectors and disc iplines \;The programme is designed to reflect the complexity of moder n toxicology\, addressing scientific\, ethical\, and regulatory challenges through multidisciplinary dialogue. \;PARC will have a significant pr esence at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The collective participation of PARC teams underlines the initiative’s critical role in advancing tox icology and public health research at the European level. \;Metabolic disruption of lipid metabolism in human liver cells presented by Neele Wew er (German Federal Institute for Risk Assessment ↗) Towards prospective identification of respiratory sensitizers: setting up a co-culture of bron chial epithelial and dendritic-like cells presented by Véronique de Bruij n (National Institute for Public Health and the Environment ↗\, Netherl ands)Involvement of glucocorticoid receptor in immunomodulation of THP-1 d erived macrophages by bisphenol A substitutes presented by Nina Franko (Fa culty of Pharmacy ↗\, Slovenia)Implementation of NAMs in Pesticide Dossi ers: Insights from PARC Project-PESTNAM presented by Emma Di Consiglio (It alian National Institute of Health ↗)Exploring Linkages between Thyroid Hormone System Disruption (THSD) and Metabolic Adverse Outcomes presented by Elisavet RenieriA Next Generation PBK model for PFOA in humans presente d by Chrysanthi Pachoulide (Wageningen University &\; Research ↗\, Ne therlands)The Genotoxic Potential of Emerging Bisphenol A Alternatives in an Advanced in vitro Zebrafish Hepatic Model presented by Alja Štern (Nat ional Institute of Biology ↗\, Slovenia)Adverse (geno)toxic effects of B PA\, its two analogues BPAP and BPC and their binary mixtures in in vitro 3D cell model presented by Martina  \;Štampar (National Institute of Biology ↗\, Slovenia)Cell dialogue in disarray: unraveling non-genotoxic carcinogens through disrupted connexin-based communication presented by P avel Babica (RECETOX ↗\, Czechia)Mechanistic Insights of BPA Alternative s on PPARγ Binding and Consequences on Adipocyte Differentiation presente d by Daniela Flores Gomez (Utrecht University ↗\, Netherlands)Cadmium in the Portuguese Diet: A Food Sustainability Perspective on Human Exposure from Plant- and Animal-Based Foods \; presented by Sónia Namorado (Po rtuguese National Institute of Health Dr. Ricardo Jorge\, Portugal) ↗Pr enatal mercury exposure and the associated risk: a call for preventive act ion based on Human Biomonitoring Data from Portuguese Pregnant Women prese nted by Sónia Namorado (Portuguese National Institute of Health Dr. Ricar do Jorge\, Portugal) \; ↗Establishment of Readiness Criteria for AI- based tools for risk assessment: READYAI presented by Joyce de Paula Souza (University of Basel ↗\, Switzerland)Assessment of the Metabolic Fate o f Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG ce lls presented by Louise Gütter (National Research Institute for Agricultu re\, Food and Environment ↗\, France)Biotransformation of the colour dev eloper Pergafast 201 in human in vitro models presented by Daniel Zalko (N ational Research Institute for Agriculture\, Food and Environment ↗\, Fr ance)How advancements in OECD genotoxicity TGs improve chemical safety ass essments and challenge retrospective data analysis for NAM based IATA deve lopment presented by Vasiliki Hatzi (Benaki Phytopathological Institute ↗\, Greece)Creation of a FAIR data policy for the Partnership for the As sessment of Risk from Chemicals (PARC). Exploring LLMs and data sciences f or identification of future topics and stakeholder interests presented by Rob Stierum (Netherlands Organization for Applied Scientific Research ↗) Use of New Approach Methodologies (NAMs) in unravelling interspecies Toxic okinetics of Enniatin B1 presented by Mariam Mahdjoub (French Agency for F ood\, Environmental and Occupational Health &\; Safety ↗)The PARC Rea l-life Mixtures Project: Mixture Risk Assessment Results of the Case Studi es on Pesticides\, PFAS and Heavy Metals presented by Hannah McKeon (Natio nal Institute for Public Health and the Environment ↗\, Netherlands)Asse ssment of the Metabolic Fate of Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG cells presented by Daniel Zalko (National Rese arch Institute for Agriculture\, Food and Environment ↗\, France)Neuroen docrine changes and oxidative stress following PFAS exposure using the Zeb rafish (Danio rerio) model \; presented by Sarah Elise Smebakk Nilsen (Norwegian University of Life Sciences ↗)Comparison of aggregate exposur e to PFAS from diet and environment sources with Spanish human biomonitori ng data \; presented by Noelia Domínguez-Morueco (Carlos III Health I nstitute ↗\, Spain)Human Choroid Plexus Organoid Model to Test Inhibitio n of Thyroid Hormone Transport across the Blood-Cerebrospinal fluid-Barrie r presented by Kim Heikamp (Vrije Universiteit Amsterdam ↗\, Netherlands )Mycotoxins from the Alternaria fungi sp. may modulate the activation of t he toll like receptor – NFkB-signalling pathway \; presented by Solv eig Krapf (National Institute of Occupational Health ↗\, Norway)Advancin g immunotoxicology with animal-free models: a novel approach for TD and TI antibody response assays presented by Martina Martina Iulini (Università degli Studi di Milano ↗\, Italy)WP3: PARC ambition for synergies and co mmunication to gain impact presented by Aglaia Koutsodimou (Independent Au thority of Public Revenue ↗\, Greece)Comparison of aggregate exposure to PFAS from diet and environment sources with Spanish human biomonitoring d ata \; presented by Domínguez-Morueco Noelia  \;(Carlos III Healt h Institute ↗\, Spain)Ensuring protocol robustness and integrity in the development of Adverse Outcome Pathway (AOP) for regulatory application pr esented by Barbara Viviani  \;(Università degli Studi di Milano ↗\, Italy) \; \; \;EUROTOX 2025 is a cornerstone event for profes sionals engaged in toxicology and chemical risk assessment. We warmly invi te all stakeholders\, scientists\, and policymakers to join this prestigio us congress in Athens. Engage in leading-edge discussions\, discover new c ollaborations\, and contribute to shaping the future of toxicology. X-ALT-DESC;FMTTYPE=text/html:

The EUROTOX 2025 – European Congress of Toxicology ↗ wil l take place from 14 to 17 September 2025 in Athens\, Greece. Recognized a s Europe’s most prominent toxicology conference\, EUROTOX gathers leadin g scientists\, regulators\, industry experts\, and academics to explore th e most pressing issues and innovations in toxicology. The scientific progr amme will emphasize emerging technologies\, advanced methodologies\, and i nterdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform for knowledge exchange and aims to foster critical discussions that will shape the future of toxicological science: \;

  • Keynote lectu res by renowned international experts
  • Sessions on AI and computati onal toxicology\, exposure science\, omics technologies\, and regulatory i nnovations
  • Dedicated space for young researchers to present their work through oral and poster presentations
  • Networking events promo ting collaboration across sectors and disciplines \;

The p rogramme is designed to reflect the complexity of modern toxicology\, addr essing scientific\, ethical\, and regulatory challenges through multidisci plinary dialogue. \;

PARC will have a significant presen ce at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The col lective participation of PARC teams underlines the initiative’s critical role in advancing toxicology and public health research at the European l evel. \;

 \;

 \;

 \;

EUROTOX 2025 is a cornerstone event for professionals engaged in toxicology and chemical risk assessment. We warmly invite all stakeholders\, scientists\, and policymakers to join this prestigious cong ress in Athens. Engage in leading-edge discussions\, discover new collabor ations\, and contribute to shaping the future of toxicology.

X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260417T193231Z END:VEVENT BEGIN:VEVENT UID:69e28acf4f77c DTSTART;VALUE=DATE:20250917 SEQUENCE:0 TRANSP:OPAQUE DTEND;VALUE=DATE:20250918 SUMMARY:European Congress of Toxicology 2025 CLASS:PUBLIC DESCRIPTION:The EUROTOX 2025 – European Congress of Toxicology ↗ will t ake place from 14 to 17 September 2025 in Athens\, Greece. Recognized as E urope’s most prominent toxicology conference\, EUROTOX gathers leading s cientists\, regulators\, industry experts\, and academics to explore the m ost pressing issues and innovations in toxicology. The scientific programm e will emphasize emerging technologies\, advanced methodologies\, and inte rdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform fo r knowledge exchange and aims to foster critical discussions that will sha pe the future of toxicological science: \;Keynote lectures by renowned international expertsSessions on AI and computational toxicology\, exposu re science\, omics technologies\, and regulatory innovationsDedicated spac e for young researchers to present their work through oral and poster pres entationsNetworking events promoting collaboration across sectors and disc iplines \;The programme is designed to reflect the complexity of moder n toxicology\, addressing scientific\, ethical\, and regulatory challenges through multidisciplinary dialogue. \;PARC will have a significant pr esence at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The collective participation of PARC teams underlines the initiative’s critical role in advancing tox icology and public health research at the European level. \;Metabolic disruption of lipid metabolism in human liver cells presented by Neele Wew er (German Federal Institute for Risk Assessment ↗) Towards prospective identification of respiratory sensitizers: setting up a co-culture of bron chial epithelial and dendritic-like cells presented by Véronique de Bruij n (National Institute for Public Health and the Environment ↗\, Netherl ands)Involvement of glucocorticoid receptor in immunomodulation of THP-1 d erived macrophages by bisphenol A substitutes presented by Nina Franko (Fa culty of Pharmacy ↗\, Slovenia)Implementation of NAMs in Pesticide Dossi ers: Insights from PARC Project-PESTNAM presented by Emma Di Consiglio (It alian National Institute of Health ↗)Exploring Linkages between Thyroid Hormone System Disruption (THSD) and Metabolic Adverse Outcomes presented by Elisavet RenieriA Next Generation PBK model for PFOA in humans presente d by Chrysanthi Pachoulide (Wageningen University &\; Research ↗\, Ne therlands)The Genotoxic Potential of Emerging Bisphenol A Alternatives in an Advanced in vitro Zebrafish Hepatic Model presented by Alja Štern (Nat ional Institute of Biology ↗\, Slovenia)Adverse (geno)toxic effects of B PA\, its two analogues BPAP and BPC and their binary mixtures in in vitro 3D cell model presented by Martina  \;Štampar (National Institute of Biology ↗\, Slovenia)Cell dialogue in disarray: unraveling non-genotoxic carcinogens through disrupted connexin-based communication presented by P avel Babica (RECETOX ↗\, Czechia)Mechanistic Insights of BPA Alternative s on PPARγ Binding and Consequences on Adipocyte Differentiation presente d by Daniela Flores Gomez (Utrecht University ↗\, Netherlands)Cadmium in the Portuguese Diet: A Food Sustainability Perspective on Human Exposure from Plant- and Animal-Based Foods \; presented by Sónia Namorado (Po rtuguese National Institute of Health Dr. Ricardo Jorge\, Portugal) ↗Pr enatal mercury exposure and the associated risk: a call for preventive act ion based on Human Biomonitoring Data from Portuguese Pregnant Women prese nted by Sónia Namorado (Portuguese National Institute of Health Dr. Ricar do Jorge\, Portugal) \; ↗Establishment of Readiness Criteria for AI- based tools for risk assessment: READYAI presented by Joyce de Paula Souza (University of Basel ↗\, Switzerland)Assessment of the Metabolic Fate o f Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG ce lls presented by Louise Gütter (National Research Institute for Agricultu re\, Food and Environment ↗\, France)Biotransformation of the colour dev eloper Pergafast 201 in human in vitro models presented by Daniel Zalko (N ational Research Institute for Agriculture\, Food and Environment ↗\, Fr ance)How advancements in OECD genotoxicity TGs improve chemical safety ass essments and challenge retrospective data analysis for NAM based IATA deve lopment presented by Vasiliki Hatzi (Benaki Phytopathological Institute ↗\, Greece)Creation of a FAIR data policy for the Partnership for the As sessment of Risk from Chemicals (PARC). Exploring LLMs and data sciences f or identification of future topics and stakeholder interests presented by Rob Stierum (Netherlands Organization for Applied Scientific Research ↗) Use of New Approach Methodologies (NAMs) in unravelling interspecies Toxic okinetics of Enniatin B1 presented by Mariam Mahdjoub (French Agency for F ood\, Environmental and Occupational Health &\; Safety ↗)The PARC Rea l-life Mixtures Project: Mixture Risk Assessment Results of the Case Studi es on Pesticides\, PFAS and Heavy Metals presented by Hannah McKeon (Natio nal Institute for Public Health and the Environment ↗\, Netherlands)Asse ssment of the Metabolic Fate of Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG cells presented by Daniel Zalko (National Rese arch Institute for Agriculture\, Food and Environment ↗\, France)Neuroen docrine changes and oxidative stress following PFAS exposure using the Zeb rafish (Danio rerio) model \; presented by Sarah Elise Smebakk Nilsen (Norwegian University of Life Sciences ↗)Comparison of aggregate exposur e to PFAS from diet and environment sources with Spanish human biomonitori ng data \; presented by Noelia Domínguez-Morueco (Carlos III Health I nstitute ↗\, Spain)Human Choroid Plexus Organoid Model to Test Inhibitio n of Thyroid Hormone Transport across the Blood-Cerebrospinal fluid-Barrie r presented by Kim Heikamp (Vrije Universiteit Amsterdam ↗\, Netherlands )Mycotoxins from the Alternaria fungi sp. may modulate the activation of t he toll like receptor – NFkB-signalling pathway \; presented by Solv eig Krapf (National Institute of Occupational Health ↗\, Norway)Advancin g immunotoxicology with animal-free models: a novel approach for TD and TI antibody response assays presented by Martina Martina Iulini (Università degli Studi di Milano ↗\, Italy)WP3: PARC ambition for synergies and co mmunication to gain impact presented by Aglaia Koutsodimou (Independent Au thority of Public Revenue ↗\, Greece)Comparison of aggregate exposure to PFAS from diet and environment sources with Spanish human biomonitoring d ata \; presented by Domínguez-Morueco Noelia  \;(Carlos III Healt h Institute ↗\, Spain)Ensuring protocol robustness and integrity in the development of Adverse Outcome Pathway (AOP) for regulatory application pr esented by Barbara Viviani  \;(Università degli Studi di Milano ↗\, Italy) \; \; \;EUROTOX 2025 is a cornerstone event for profes sionals engaged in toxicology and chemical risk assessment. We warmly invi te all stakeholders\, scientists\, and policymakers to join this prestigio us congress in Athens. Engage in leading-edge discussions\, discover new c ollaborations\, and contribute to shaping the future of toxicology. X-ALT-DESC;FMTTYPE=text/html:

The EUROTOX 2025 – European Congress of Toxicology ↗ wil l take place from 14 to 17 September 2025 in Athens\, Greece. Recognized a s Europe’s most prominent toxicology conference\, EUROTOX gathers leadin g scientists\, regulators\, industry experts\, and academics to explore th e most pressing issues and innovations in toxicology. The scientific progr amme will emphasize emerging technologies\, advanced methodologies\, and i nterdisciplinary collaboration\, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform for knowledge exchange and aims to foster critical discussions that will shape the future of toxicological science: \;

  • Keynote lectu res by renowned international experts
  • Sessions on AI and computati onal toxicology\, exposure science\, omics technologies\, and regulatory i nnovations
  • Dedicated space for young researchers to present their work through oral and poster presentations
  • Networking events promo ting collaboration across sectors and disciplines \;

The p rogramme is designed to reflect the complexity of modern toxicology\, addr essing scientific\, ethical\, and regulatory challenges through multidisci plinary dialogue. \;

PARC will have a significant presen ce at EUROTOX 2025\, with contributions from researchers representing 12 institutions across 9 European countries. The col lective participation of PARC teams underlines the initiative’s critical role in advancing toxicology and public health research at the European l evel. \;

 \;

 \;

 \;

EUROTOX 2025 is a cornerstone event for professionals engaged in toxicology and chemical risk assessment. We warmly invite all stakeholders\, scientists\, and policymakers to join this prestigious cong ress in Athens. Engage in leading-edge discussions\, discover new collabor ations\, and contribute to shaping the future of toxicology.

X-MICROSOFT-CDO-ALLDAYEVENT:TRUE DTSTAMP:20260417T193231Z END:VEVENT END:VCALENDAR